| |
CLL-stage C immune
(6 patients) |
CLL-stage C infiltrative
( 25 patients) |
p |
| Median age ( years) |
68 |
73 |
NS |
| Male (%) |
66 |
70 |
NS |
| Hb×109/L |
10.4 |
10 |
NS |
| WBC ×109/L |
34.2 |
45.1 |
NS |
| absolute Ly count×109/L |
18.6 |
25.4 |
NS |
| Platelet count × 109/L |
86 |
91 |
NS |
| Bone marrow infiltration % |
49 |
84 |
0.05 |
| β2microglobuline >2.5mg/L% |
50 |
70 |
0.01 |
| FORD values (mmol/L) |
0.39-0.84 |
0.41-0.96 |
NS |
| FORT values (mmol/L) |
2.7-3.8 |
2.5 - 3.4 |
NS |
| Overall survival, years |
5.7 |
2.8 |
0.01 |
|
